CAR-T CELL THERAPY BREAKTHROUGH IN SOLID TUMOURS
CAR-T CELL THERAPY BREAKTHROUGH IN SOLID TUMOURS Why in the News? Scientists have developed a highly sensitive receptor (HIT receptor) that enables CAR-T cells to detect low-level tumour proteins. The breakthrough could make CAR-T therapy effective against solid cancers like kidney and ovarian cancer, overcoming a long-standing limitation. Key scientific advancement Concept innovation: Uses an …
Read More
